{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-confidentiality-and-data-protection-controls”
},
“headline”: “SOP for Confidentiality and Data Protection Controls”,
“description”: “This SOP establishes procedures for confidentiality and data protection controls in clinical trials, ensuring compliance with FDA, EMA, CDSCO, WHO, GDPR, HIPAA, and ICH GCP requirements. It covers subject privacy, anonymization, encryption, secure data transfer, and breach management.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 21/12/2025
Standard Operating Procedure for Confidentiality and Data Protection Controls
| SOP No. | CR/OPS/094/2025 |
| Supersedes | NA |
| Page No. | 1 of 43 |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to define processes for maintaining confidentiality and implementing data protection controls in clinical trials. These measures ensure
Scope
This SOP applies to sponsors, CROs, investigators, site staff, vendors, and data management teams handling clinical trial records, including paper, electronic, and hybrid systems. It covers confidentiality agreements, anonymization, pseudonymization, encryption, data sharing, secure transfer, storage, and breach notification.
Responsibilities
- Sponsor: Defines data protection policies and ensures oversight.
- Investigator: Protects subject confidentiality at the site level.
- QA: Audits confidentiality and data protection systems.
- Data Management: Implements technical and organizational data security measures.
- Vendors: Comply with sponsor confidentiality agreements and data security requirements.
Accountability
The Sponsor is accountable for ensuring global compliance with data protection laws. Investigators are accountable for safeguarding subject confidentiality at trial sites. QA ensures oversight and inspection readiness.
Procedure
1. Confidentiality Agreements
1.1 All staff, CROs, and vendors must sign confidentiality agreements before accessing trial data.
1.2 Agreements must include provisions for subject privacy, intellectual property, and proprietary data.
2. Subject Data Protection
2.1 Assign unique subject identifiers; do not use directly identifiable information in reports.
2.2 Anonymize or pseudonymize subject data before transfer or storage.
2.3 Maintain Subject Confidentiality Log (Annexure-1).
3. Data Security Controls
3.1 Implement encryption for electronic data at rest and during transfer.
3.2 Restrict access to data using role-based controls.
3.3 Document data access in Access Control Log (Annexure-2).
4. Secure Data Transfer
4.1 Use secure portals, encrypted emails, or validated EDC systems.
4.2 Record all data transfers in Data Transfer Log (Annexure-3).
5. Breach Notification
5.1 Report suspected or confirmed breaches within 24 hours to Sponsor and QA.
5.2 Initiate Breach Investigation Log (Annexure-4).
5.3 Notify regulatory authorities per GDPR/HIPAA requirements.
6. Archiving and Retention
6.1 Archive data in secure, access-controlled facilities or validated eArchives.
6.2 Retain confidentiality documentation as per regulatory timelines.
7. Training
7.1 All staff handling subject data must undergo annual training on confidentiality and data protection.
7.2 Training must be documented in Training Log (Annexure-5).
Abbreviations
- SOP: Standard Operating Procedure
- QA: Quality Assurance
- CRO: Contract Research Organization
- EDC: Electronic Data Capture
- GDPR: General Data Protection Regulation
- HIPAA: Health Insurance Portability and Accountability Act
- TMF: Trial Master File
- ISF: Investigator Site File
Documents
- Subject Confidentiality Log (Annexure-1)
- Access Control Log (Annexure-2)
- Data Transfer Log (Annexure-3)
- Breach Investigation Log (Annexure-4)
- Training Log (Annexure-5)
References
- ICH E6(R2/R3) – Confidentiality and Data Protection
- FDA – Guidance on Data Privacy in Clinical Trials
- EMA – Clinical Data Protection Standards
- CDSCO – Data Protection in Clinical Trials
- WHO – Data Privacy and Confidentiality Guidelines
- GDPR – General Data Protection Regulation
- HIPAA – Health Data Privacy Rules
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, Data Protection Officer |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Head Clinical Quality |
Annexures
Annexure-1: Subject Confidentiality Log
| Date | Subject ID | Data Handling Method | Responsible |
|---|---|---|---|
| 01/09/2025 | SUBJ-501 | Anonymized before transfer | Data Manager |
Annexure-2: Access Control Log
| Date | User | Role | Data Accessed | Authorized By |
|---|---|---|---|---|
| 05/09/2025 | Meena Sharma | CRA | eCRF | Data Manager |
Annexure-3: Data Transfer Log
| Date | Data Set | Method | Sender | Receiver |
|---|---|---|---|---|
| 10/09/2025 | PK Dataset | Secure Portal | Site Coordinator | Sponsor Data Manager |
Annexure-4: Breach Investigation Log
| Date | Incident | Reported By | Action Taken | Status |
|---|---|---|---|---|
| 12/09/2025 | Unauthorized access attempt | QA Officer | Blocked user, reported to Sponsor | Closed |
Annexure-5: Training Log
| Date | Name | Role | Training Topic | Trainer |
|---|---|---|---|---|
| 01/09/2025 | Ravi Kumar | Data Manager | GDPR and HIPAA | QA Officer |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Head Clinical Quality |
For more SOPs visit: Pharma SOP